Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis – A comprehensive review
- 1 September 2021
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 187, 988-998
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation
- All-India Institute of Medical Sciences
- Department of Science and Technology, Ministry of Science and Technology, India
- Indian Council of Medical Research
This publication has 56 references indexed in Scilit:
- Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia SpeciesClinical Microbiology Reviews, 2011
- Apophysomyces elegans : Epidemiology, Amplified Fragment Length Polymorphism Typing, and In Vitro Antifungal Susceptibility PatternJournal of Clinical Microbiology, 2010
- Recent Advances in the Treatment of MucormycosisCurrent Infectious Disease Reports, 2010
- The high affinity iron permease is a key virulence factor required forRhizopus oryzaepathogenesisMolecular Microbiology, 2010
- The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic miceJournal of Clinical Investigation, 2010
- Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological DisordersAntioxidants & Redox Signaling, 2009
- Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for MucormycosisAntimicrobial Agents and Chemotherapy, 2009
- Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral MucormycosisClinical Infectious Diseases, 2008
- Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosisProceedings of the National Academy of Sciences, 2008
- Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-Like Receptor 2 Induction but Display Relative Resistance to Oxidative DamageAntimicrobial Agents and Chemotherapy, 2008